Market
Which public health policy will RFK Jr. prioritize if confirmed as HHS Secretary?
2
Resolution / Starting Odds
End taxpayer-funded junk food in food stamps • 25%
Promote domestic medicine production • 25%
Ensure vaccines fully tested before release • 25%
Address chemicals in food • 25%
Official policy announcements from HHS or government
Story
RFK Jr. Pushes for Daughter-in-Law at CIA, Faces Opposition as HHS Nominee
Dec 11, 2024, 04:16 PM
Robert F. Kennedy Jr., nominated by President Donald Trump for the position of Secretary of Health and Human Services, is reportedly advocating for his daughter-in-law, Amaryllis Fox Kennedy, to be appointed as the deputy director of the CIA. This push is motivated by RFK Jr.'s belief that the CIA was involved in the assassination of his uncle, President John F. Kennedy. Over 75 Nobel laureates have expressed opposition to Kennedy's potential role at HHS, citing concerns about the impact on public health and research. Meanwhile, Kennedy's tenure at HHS could lead to significant changes in healthcare policy, including ending taxpayer-funded junk food in food stamps, promoting domestic medicine production, ensuring vaccines are fully tested before release, and addressing concerns about chemicals in food.
View original story
Similar markets
Abortion policy • 25%
Vaccine policy • 25%
Healthy food initiative • 25%
Other health policy • 25%
Other • 25%
Vaccine Policy • 25%
Healthcare Reform • 25%
Public Health Campaign • 25%
Other • 25%
Addressing Chronic Diseases • 25%
Food Safety • 25%
Tackling Big Pharma • 25%
Vaccine policy changes • 25%
Resignation or removal • 25%
No major changes • 25%
Focus on other health issues • 25%
Other • 25%
Vaccine Policy • 25%
Chronic Disease • 25%
Health Risks and Climate Change • 25%
Vaccine Policy • 25%
Obesity Crisis • 25%
Food Regulation • 25%
Abortion Policy • 25%
Vaccine policy reform • 25%
Other initiatives • 25%
Healthcare system overhaul • 25%
Food regulation reform • 25%
Food quality standards • 25%
Pharmaceutical regulations • 25%
Healthcare access • 25%
Other • 25%
Stance on pharmaceutical companies • 25%
General bipartisan cooperation • 25%
Other reasons • 25%
Stance on food industry • 25%
Looser vaccine regulations • 25%
Stricter vaccine regulations • 25%
Other major health policy changes • 25%
No significant changes • 25%
Healthcare Reform • 25%
Vaccine Policy • 25%
Pharmaceutical Regulation • 25%
Other • 25%
Pro-vaccine stance • 25%
No statement • 25%
Neutral stance • 25%
Anti-vaccine stance • 25%